Lawmakers press FDA for action on addictive painkillers

Lawmakers asked the FDA for a specific timeline on how quickly hydrocodone medications could be taken from a Schedule III drug to a Schedule II, which would make them harder to get. 

“The American people have waited too long for action from this agency,” the lawmakers wrote in a letter to the FDA. “Your own experts agreed it is time we take the necessary steps to address this deadly epidemic.”

ADVERTISEMENT

Reps. Vern Buchanan (R-Fla.) and Edward MarkeyEdward (Ed) John MarkeyKennedy, Markey neck-and-neck in Massachusetts primary: poll Overnight Energy: EPA to regulate 'forever chemicals' in drinking water | Trump budget calls for slashing funds for climate science centers | House Dems urge banks not to fund drilling in Arctic refuge Democratic senators criticize plan that could expand Arctic oil and gas development MORE (D-Mass.) signed the letter, along with Sens. Joe ManchinJoseph (Joe) ManchinWhere do we go from here? Conservation can show the way Lawmakers push back at Trump's Pentagon funding grab for wall Overnight Health Care: Appeals court strikes down Medicaid work requirements | Pelosi's staff huddles with aides on surprise billing | Senate Dems pressure Trump to drop ObamaCare lawsuit MORE (D-W.Va.), Mark KirkMark Steven KirkOn the Trail: Senate GOP hopefuls tie themselves to Trump Biden campaign releases video to explain 'what really happened in Ukraine' Why Republicans are afraid to call a key witness in the impeachment inquiry MORE (R-Ill.), John RockefellerJohn (Jay) Davison RockefellerBottom Line World Health Day: It's time to fight preventable disease Lobbying World MORE (D-W.Va.), Charles SchumerCharles (Chuck) Ellis SchumerWhite House asking Congress for .5 billion to fight coronavirus Hillicon Valley: Agencies play catch-up over TikTok security concerns | Senate Dems seek sanctions on Russia over new election meddling | Pentagon unveils AI principles Senate Democrats urge Trump administration to impose sanctions on Russia for election interference MORE (D-N.Y.) and Kirsten GillibrandKirsten GillibrandNow is the time for a US data protection agency The Hill's Campaign Report: Warren up, Bloomberg down after brutal debate Ginsburg, accepting lifetime achievement award, urges working fathers to take an active role in kids' lives MORE (D-N.Y.).

The lawmakers noted that the number of chronic abusers of hydrocodone in the U.S. has increased to more than 24 million since 1999, when Congress originally asked the agencies to work on the issue. 

“It has been 14 years since the initial petition requesting that the FDA and [the Drug Enforcement Agency] evaluate the proper scheduling of hydrocodone combination drugs. In those 14 years, there has been a staggering number of hydrocodone related deaths and a drastic increase in non-medical users of these products,” lawmakers wrote.

Moving hydrocodone combination drugs from a Schedule III to a Schedule II classification would make a doctor’s written prescription mandatory to obtain the medications, among other restrictions.  

Lawmakers said 139 million prescriptions of hydrocodone-based painkillers have been sold since 2010, making them the top-selling controlled substance in America.

The FDA announced it would move to address the availability of the drugs last month, following a 19-10 vote by an advisory panel that agreed new restrictions are needed.